Last Updated on eMC 27-07-2017 View medicine  | Actavis UK Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 3 - how to take/use
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 4 - possible side effects

Reasons for adding or updating:

  • Change of trade or generic name

Reasons for adding or updating:

  • Change of inactive ingredient

Reasons for adding or updating:

  • Introduction of new pack/pack size

Reasons for adding or updating:

  • Change to date of revision
  • Introduction of new pack/pack size

Reasons for adding or updating:

  • Change due to user-testing of patient information

Reasons for adding or updating:

  • Transfer to upgraded management system

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects

Reasons for adding or updating:

  • Improved Electronic Presentation

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC